Hyperbaric oxygen alone or combined with 5-FU attenuates growth of DMBA-induced rat mammary tumors

被引:53
作者
Stuhr, LEB
Iversen, VV
Straume, O
Mæhle, BO
Reed, RK
机构
[1] Univ Bergen, Dept Biomed, Div Physiol, N-5009 Bergen, Norway
[2] Haukeland Univ Hosp, Dept Pathol, Gades Inst, Bergen, Norway
关键词
Hyperbaric oxygen; 5-FU; tumor-reduction; angiogenesis; immunohistochemistry; rats;
D O I
10.1016/j.canlet.2004.02.012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We tested the hypothesis that hyperbaric oxygen (HBO) alone and with chemotherapy (5-FU) attenuates tumor growth of DMBA-induced tumors in rats. Six series were performed: (1) Controls (air and vehicle 0.9% NaCl i.p.), (2) 5-FU (0.2 mg/kg i.p.), (3) HBO (2 bar for 90 min and vehicle), (4) HBO and 5-FU, (5) HBO (11days) and air (next 12 days), (6) HBO (23 days). All treatments were applied on days 1, 4, 7, 10 (Series 1-4), as well as on days 14, 17 and 23 (Series 5-6). Tumor diameter increased by 76.7 and 41.2% in untreated controls and in the 5-FU group, respectively, after 10 days. Tumor size fell by 17-24.2% in the HBO groups and by 35.5% when combined with 5-FU (P<0.05 compared to HBO). HBO treatment reduced the total number of blood vessels in the tumors. After completion of HBO treatment tumor size increased, but statistically insignificant, during the next 12 days. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:35 / 40
页数:6
相关论文
共 26 条
[1]   PROOXIDANT STATES AND TUMOR PROMOTION [J].
CERUTTI, PA .
SCIENCE, 1985, 227 (4685) :375-381
[2]  
CHURCHILLDAVIDSON I, 1955, LANCET, V1, P1091
[3]  
DAVIS JC, 1987, CLIN PODIATR MED SUR, V4, P237
[4]  
DETTMER CM, 1968, AMER J ROENTGENOL RA, V102, P804
[5]  
FELDMEIER JJ, 1993, UNDERSEA HYPERBAR M, V20, P337
[6]  
FELDMEIER JJ, 1994, UNDERSEA HYPERBAR M, V21, P467
[7]   Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1α [J].
Freedman, SJ ;
Sun, ZYJ ;
Poy, F ;
Kung, AL ;
Livingston, DM ;
Wagner, G ;
Eck, MJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (08) :5367-5372
[8]  
Gray LH, 1953, BRIT J RADIOL, V26, P683
[9]  
Heng M C, 2000, Ostomy Wound Manage, V46, P18
[10]  
HUGGINS CB, 1979, EXPT LEUKEMIA MAMMAR